Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Wales
100%
Clinical Practice
100%
Paliperidone
100%
Treatment Continuation
100%
Long-acting Injectable Aripiprazole
100%
Schizophrenia
66%
Fisher's Exact Test
66%
Clozapine
66%
Adverse Effects
33%
Patient Preference
33%
Non-associated
33%
Illness
33%
Psychiatry
33%
Treatment Options
33%
Demographic Factors
33%
NHS Wales
33%
Previous Treatment
33%
Common Phenomena
33%
Pharmacy Records
33%
Long-acting Injectable
33%
Reasons for Discontinuation
33%
Age at Initiation
33%
Inpatient Status
33%
Naturalistic Study
33%
Lost to Follow-up
33%
Treatment Discontinuation
33%
Case Note Review
33%
Treatment Refractory
33%
Off-label Use
33%
Age at Diagnosis
33%
Health Board
33%
Patient numbers
33%
Statistically Significant Difference
33%
Retrospective Cases
33%
Product License
33%
Medicine and Dentistry
Aripiprazole
100%
Clozapine
100%
Paliperidone
100%
Injection
100%
Fisher Exact Test
100%
Schizophrenia
100%
Diseases
50%
Oral
50%
Outpatient
50%
Treatment Option
50%
Psychiatry
50%
Demographic Factor
50%
Off-Label Use
50%
Adverse Effect
50%
Nursing and Health Professions
Clinical Practice
100%
Injection
100%
Clozapine
100%
Aripiprazole
100%
Schizophrenia
100%
Paliperidone
100%
Fisher Exact Test
100%
Diseases
50%
Outpatient
50%
Off-Label Use
50%
Adverse Effect
50%
Pharmacology, Toxicology and Pharmaceutical Science
Aripiprazole
100%
Paliperidone
100%
Clozapine
100%
Schizophrenia
100%
Diseases
50%
Off-Label Use
50%
Adverse Effect
50%